Clinical Trials Directory

Trials / Sponsors / Hebei Yanda Ludaopei Hospital

Hebei Yanda Ludaopei Hospital

Academic / Other · 15 registered clinical trials.

StatusTrialPhaseStarted
UnknownStudy on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients
Nutrition Aspect of Cancer, Stem Cell Transplant Complications
N/A2022-11-01
CompletedLILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia
Phase 12022-06-24
TerminatedCD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL)
Refractory and Relapsed B Cell Acute Leukemia
Phase 12020-10-10
UnknownA Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MM
Multiple Myeloma
EARLY_Phase 12020-06-01
UnknownA Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL
B-cell Non Hodgkin Lymphoma
EARLY_Phase 12020-06-01
CompletedCD19/CD20 Dual-CAR-T in B-cell Leukemia Patients
B-cell Leukemia
Phase 12020-03-10
CompletedCD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients
B-cell Lymphoma
Phase 12020-03-01
CompletedEBV-TCR-T Cells for EB Virus Infection After HSCT
EBV Emia and EBV Positive PTLD After Allogenic HSCT
Phase 12020-02-10
CompletedCMV-TCR-T Cells for CM Virus Infection After HSCT
CMV Infection or Reactivation After Allogenic HSCT
Phase 12019-12-19
UnknownA Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
B-cell Acute Lymphoblastic Leukemia
EARLY_Phase 12019-10-22
CompletedCD19-CAR-T in B-cell Malignancies Patients
B-cell Malignancy
Phase 12019-08-01
CompletedCD19-Synthetic T Cell Antigen Receptor(STAR)-T in B-cell Malignancies Patients
B Cell Malignancy
Phase 12019-07-01
UnknownA Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
B-cell Acute Lymphoblastic Leukemia
EARLY_Phase 12019-01-17
CompletedA Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
B-cell Acute Lymphoblastic Leukemia
EARLY_Phase 12019-01-17
UnknownA Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Phase 12019-01-08